ISLAND PHARMACEUTICALS LIMITED (ILA)
AI Coverage Rating: Moderate
ASX AI Signals has generated 2 signal(s) for ILA during the last 90 days, indicating Moderate trading activity
Latest ILA Signals | |
| 19/05/2026 | BUY |
| 07/05/2026 | SELL |
ILA Share Price | |
| Current Price | $0.375 |
| 52 Week High | $0.570 |
| 52 Week Low: | $0.145 |
| Trading at (% of 52 Week High) | 65.79% |
Business Overview
Island Pharmaceuticals Limited (ASX: ILA) is an Australian-based pharmaceutical company focused on developing and commercializing medical cannabis products. The company aims to provide high-quality, research-backed cannabinoid therapies for various health conditions.
ASX Sector Overview
Sector: Pharmaceuticals, Biotechnology & Life Sciences
The Pharmaceuticals, Biotechnology & Life Sciences sector on the ASX includes companies involved in the development, production, and commercialization of drugs, medical devices, and biotechnology products. This sector covers activities such as research and development of new medicines, genetic testing, and innovative healthcare technologies. Companies often work on treatments for diseases, including cancer, infectious diseases, and chronic conditions. The sector plays a crucial role in advancing medical science and improving patient care through innovation.
Latest AI Recommendation
The BUY signal for ISLAND PHARMACEUTICALS LIMITED (ILA) is supported by positive momentum and potential growth in the pharmaceutical sector. However, the relatively low current price and market volatility introduce moderate risk, warranting a cautious approach.
Latest ISLAND PHARMACEUTICALS LIMITED(ILA) News
Unlock All ASX AI Signals
Get access to daily BUY & SELL signals, advanced AI analysis, watchlists and email alerts.
14 Day Free Trial • Cancel Anytime • Founders Price $15/month
Start My Free Trial